Aby J. Mathew, EVP & Chief Scientific Officer at BIOLIFE SOLUTIONS INC (BLFS), sold 30,000 shares at $23.17 ($696K) on 2024-10-16, disclosed to the SEC on 2024-10-17.
Scheduled sale ($696k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.28 | 10,000 | $233K | 33.4% |
| 2 | $23.17 | 10,000 | $232K | 33.3% |
| 3 | $23.17 | 10,000 | $232K | 33.3% |
| Total | $23.21 avg | 30,000 | $696K | 100% |
| Filing → |
| BLFS | SELL | 2025-12-17 | $16K | — | Filing → |
| BLFS | SELL | 2025-11-28 | $14K | — | Filing → |
| BLFS | SELL | 2025-10-14 | $14K | — | Filing → |